Page last updated: 2024-11-07

dehydroepiandrosterone and Parkinson Disease, Secondary

dehydroepiandrosterone has been researched along with Parkinson Disease, Secondary in 2 studies

Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choe, MA1
An, GJ1
Koo, BS1
Jeon, S1
Bélanger, N1
Grégoire, L1
Bédard, P1
Di Paolo, T1

Other Studies

2 other studies available for dehydroepiandrosterone and Parkinson Disease, Secondary

ArticleYear
Effect of DHEA on recovery of muscle atrophy induced by Parkinson's disease.
    Journal of Korean Academy of Nursing, 2011, Volume: 41, Issue:6

    Topics: Animals; Corpus Striatum; Dehydroepiandrosterone; Extracellular Signal-Regulated MAP Kinases; Male;

2011
Estradiol and dehydroepiandrosterone potentiate levodopa-induced locomotor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys.
    Endocrine, 2003, Volume: 21, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dehydroepiandrosterone; Dopamine Agents; Dose

2003